Recruiting Studies
Advanced SearchData: ClinicalTrials.gov · Source of record for eligibility and locations
Top Cities for Sjogrens Syndrome Clinical Trials
Sjogrens Syndrome clinical trials are recruiting across 43 cities. Here are the cities with the most active studies:
Sjogrens Syndrome Trial Phases
9 research organizations are sponsoring sjogrens syndrome trials.
About Sjogrens Syndrome
Sjogren's syndrome is a chronic autoimmune disorder in which the immune system attacks the glands that produce moisture, causing dry eyes and dry mouth. It can also affect joints, thyroid, kidneys, and other organs. Treatment focuses on relieving symptoms and may include immunosuppressive medications.
Clinical trials are advancing new treatments for sjogrens syndrome. Currently, 10 studies are recruiting a combined 1,944 participants across the United States. Research is being conducted by 9 organizations including Amgen, National Institute of Dental and Craniofacial Research (NIDCR), Vor Biopharma and 6 others.
2026 Sjogrens Syndrome Research Landscape
As of July 2026, the sjogrens syndrome clinical trial landscape includes 10 actively recruiting studies across 43 cities in the United States. These studies are collectively seeking 1,944 participants, with an average enrollment target of 194 per study.
The research spans multiple phases of development: 3 studies are in PHASE2, 2 studies are in PHASE3, 2 studies are in PHASE4, 1 study is in PHASE1, 1 study is in NA. The presence of Phase 3 trials indicates that some sjogrens syndrome treatments are in late-stage testing and may be approaching regulatory review.
Research is being led by 9 different organizations, including Amgen, National Institute of Dental and Craniofacial Research (NIDCR), Vor Biopharma, Immunovant Sciences GmbH, Resolve Therapeutics, and 4 others.
Geographically, sjogrens syndrome trials are most concentrated in Flagstaff, Arizona (2 trials); Glendale, Arizona (2 trials); Tucson, Arizona (2 trials); Covina, California (2 trials); Fort Collins, Colorado (2 trials) and 7 other cities.
Featured Sjogrens Syndrome Studies
Highlighted recruiting studies for sjogrens syndrome, selected by enrollment size and research scope.
A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)
The primary objective of this study is to evaluate the long-term safety and tolerability of dazodalibep.
The Pathogenesis and Natural History of Sjogren's Disease
Background: -Sjogren s Disease (formerly: Sjogrens Syndrome, Sj(SqrRoot)(Delta)gren s syndrome) is a disease that affects about 1-4 million Americans. It is more common in women. It mainly affects the glands that produce saliva and tears, leading to dry eyes and dry mouth. The cause of Sjogren s Disease is unknown, but inflammation plays an important role. The purpose of this study is to learn mo...
Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease
Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease (UPSTREAM SjD)
Frequently Asked Questions About Sjogrens Syndrome Clinical Trials
Are there sjogrens syndrome clinical trials near me?
Yes, there are 10 sjogrens syndrome clinical trials currently recruiting across 43+ cities in the United States, including Flagstaff, Arizona; Glendale, Arizona; Tucson, Arizona. Browse the studies above to find one at a location convenient for you.
How do I join a sjogrens syndrome clinical trial?
To join a sjogrens syndrome clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.
Are sjogrens syndrome clinical trials free?
Yes, participation in sjogrens syndrome clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.
What types of sjogrens syndrome treatments are being studied?
Current sjogrens syndrome clinical trials are testing a range of approaches across PHASE2 (3 studies), PHASE3 (2 studies), PHASE4 (2 studies), PHASE1 (1 study), NA (1 study). These include new drugs, combination therapies, medical devices, and other interventions sponsored by 9 research organizations.
Is it safe to participate in sjogrens syndrome clinical trials?
Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.
Data updated July 16, 2026 from ClinicalTrials.gov
About This Data
Data: ClinicalTrials.gov · Source of record for eligibility and locations
Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.
Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.
Page reviewed by the HelloStudys Research Team · Last updated July 16, 2026 · Data from ClinicalTrials.gov